Skip to main content
Equibles

Russell Investments Group, Ltd.

Position in LRMR — Larimar Therapeutics, Inc.

CIK 1692234 Seattle, WA
Back to LRMR Full portfolio

Position in LRMR

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$83,459
+$67,309 QoQ
Shares Held
27,364
+662.4% QoQ
Ownership
0.026%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#87
of 162 holders
Holding Since
Mar 2020
12 quarters on record
Voting authority Sole 92% Shared 0% None 8%

Common Shares in LRMR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Russell Investments Group, Ltd. holds $1,504,360,847 across 308 Biotechnology names. LRMR ranks #212 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 336,990 $167,393,033
2 REGN
Regeneron Pharmaceuticals, Inc.
 230,151 $143,508,345
3 RPRX
Royalty Pharma plc
 1,694,250 $94,996,587
4 INCY
Incyte Corp
 425,616 $48,247,822
5 ALNY
Alnylam Pharmaceuticals, Inc.
 158,228 $47,631,369
6 BMRN
Biomarin Pharmaceutical Inc
 783,148 $44,811,725
7 LGND
Ligand Pharmaceuticals Inc
 120,304 $38,026,888
8 PTCT
Ptc Therapeutics, Inc.
 418,025 $34,098,295

All Filings in LRMR

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $83,459 27,364
2026-03-31 $16,150 3,589
2025-12-31 $22,542 5,917
2025-09-30 $15,658 4,848
2025-06-30 $329 114
2025-03-31 $414 193
2024-06-30 $12,723 1,755
2021-03-31 $192,311 13,163
2020-12-31 $281,819 13,163
2020-09-30 $199,682 13,163
2020-06-30 $169,144 13,163